Noriaki Iwase

This inventor holds 13 USPTO granted patents, plus 3 CIPO patents and 5 EPO patents. Top assignees: Ube Industries, Inc., Daiichi Sankyo Company, Limited. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriaki Iwase. Retrieved from https://idiyas.com/inventor/noriaki-iwase

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 69.2

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 9(Granted Patents)

Location History:

Yamaguchi, JP (2015 - 2016)
Ube, JP (1999 - 2021)

Company Filing History:

Daiichi Sankyo Company, Limited

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12304913 - Dihydropyrrolopyrazole derivative (2025-05-20),

2. 10968238 - Substituted dihydropyrrolopyrazole compound (2021-04-06),

3. 10894798 - Substituted dihydropyrrolopyrazole derivative (2021-01-19),

4. 10597375 - Halogen-substituted heterocyclic compound (2020-03-24),

5. 10273252 - Substituted dihydropyrrolopyrazole derivative (2019-04-30),

6. 10131679 - Substituted dihydropyrrolopyrazole compound (2018-11-20),

7. 10023554 - Halogen-substituted heterocyclic compound salt (2018-07-17),

8. 10000463 - Halogen-substituted heterocyclic compound (2018-06-19),

9. 9676720 - Substituted biaryl compound (2017-06-13),

10. 9321747 - Acid addition salt of substituted pyridine compound (2016-04-26),

11. 9187450 - Substituted pyridine compound (2015-11-17),

12. 8450319 - Pyrrolopyridazinone compound (2013-05-28),

13. 5994553 - Method for preparing 2-mercaptothiazole (1999-11-30),

Title: Noriaki Iwase: Innovator in Pharmaceutical Chemistry

Introduction

Noriaki Iwase is a prominent inventor based in Ube, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 13 patents. His work primarily focuses on the development of novel compounds with potential therapeutic applications.

Latest Patents

Among his latest patents is a dihydropyrrolopyrazole derivative, which provides a compound represented by a specific general formula. This invention includes pharmacologically acceptable salts and highlights the versatility of the compound's structure. Another notable patent involves a substituted dihydropyrrolopyrazole compound, detailing methods for producing the compound and its various structural possibilities.

Career Highlights

Noriaki Iwase has worked with reputable companies such as Ube Industries, Inc. and Daiichi Sankyo Company, Limited. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Throughout his career, Iwase has collaborated with notable colleagues, including Shigeyuki Kono and Shigeru Ushiyama. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Noriaki Iwase's contributions to pharmaceutical chemistry through his innovative patents and collaborations underscore his importance in the field. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.